Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Abiraterone Acetate

Zytiga Prednisone Combo Metastatic Castration-Resistant Prostate Cancer Trial Unblinded

A new statement by Janssen Research & Development, LLC informs that they have unblinded the Phase 3 study, COU-AA-302, which shows that Zytiga (abiraterone acetate), when taken alongside prednisone, is effective in treating mildly symptomatic or asymptomatic patients who are suffering from metastatic castration-resistant prostate cancer (CRPC) and have not gone through chemotherapy. … Zytiga Prednisone Combo Metastatic Castration-Resistant Prostate Cancer Trial Unblinded   



miscellaneous diseases1 - rennin-angiotensin system1 - advanced prostate cancer8 - cardiovascular disease5 - urinary urgency1 - heart dysfunction1 - post-operative kidney failure1 - blood vessels3 - investigational aurora kinase1 - psa21 - hepatolenticular degeneration1 - diabetes16 - sex life1 - tras1 - embryonic urothelium1 - matrix component3 - ureteral calculi1 - testosterone6 - journal of endourology1 - sexual function2 - prostate cancer cells2 - high blood pressure7 - alpha blockers1 - yeshiva university1 - renal capsule1 - congenital malformations1 - bladder cancer8 - dehydration1 - high blood sugar1 - malignant cancer1 -